Peripheral Nerve Stimulation Therapy for Atrial Fibrillation

Inclusion Criteria: * At least 22 years of age and less than 80 years of age * Diagnosed with paroxysmal atrial fibrillation, as documented on ECG, trans-telephonic monitoring (TTM), cardiac event monitoring, Holter monitoring, or implantable loop recording (episodes must be longer than 30 seconds to qualify) * At least one symptomatic atrial fibrillation episodes per month over the last three months * AF burden of at least 5%, as measured within the past 3 months, with no change in AF treatment since measurement * Willing to stay on stable medications for the duration of the study * Able and willing to use their smartphone to download the application associated with the Cardiac Measurement Device * Competent and willing to provide written, informed consent to participate in the study Exclusion Criteria: * Prior cardiac ablation, or cardiac ablation planned within 6 weeks of Visit 1 * Cardioversion procedure performed within the last 12 weeks * Valvular atrial fibrillation by transthoracic echocardiography * Left atrial anteroposterior diameter greater than 5.5 cm by transthoracic echocardiography * Prior or planned cardiac transplantation or cardiac surgery * Cerebral ischemic event (stroke or transient ischemic attack) within the last 6 months * Myocardial infarction within the last 6 months * Heart failure (NYHA class III or IV) * Left ventricular ejection fraction less than 35% * Recurrent vaso-vagal syncopal episodes * Unilateral or bilateral vagotomy * Hemodynamic instability * Structural heart damage * Implanted active electrical medical device, such as pacemaker, implantable loop recorders, defibrillator, or deep brain stimulator * Implanted metal or electrical devices in the head or treated hand * Not currently on anticoagulants * History of epilepsy or seizures * Peripheral neuropathy affecting the upper left extremity * Pregnancy, anticipated pregnancy, or nursing during the study * Unable or unwilling to comply fully with study procedures and followup, including atrial fibrillation diary requirements * Known allergy to any of the device materials that are in contact with prospective subject's skin * Current participation, or previous participation within the last 30 days, in another interventional clinical trial that may confound the results of this study, unless otherwise approved by the Sponsor * Subjects unable to communicate with the Investigator and study staff * Presence of any health condition that should preclude participation in this study, per the Investigator's opinion